About Intera Oncology
Intera Oncology is a company based in Wellesley (United States) founded in 2019 by Jonathan Reis was acquired by Boston Scientific in November 2024. Intera Oncology offers products and services including Intera 3000 HAI Pump. Intera Oncology operates in a competitive market with competitors including TriSalus Life Sciences, Cooler Heads, Luminate Medical, Delcath and Cognos Therapeutics, among others.
- Headquarter Wellesley, United States
- Founders Jonathan Reis
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Boston Scientific
(Nov 25, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intera Oncology
Intera Oncology offers a comprehensive portfolio of products and services, including Intera 3000 HAI Pump.
Implantable pump for delivering chemotherapy directly to the liver.
People of Intera Oncology
Unlock access to complete
Unlock access to complete
Funding Insights of Intera Oncology
Detailed funding history for Intera Oncology
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Intera Oncology
Intera Oncology has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wide range of medical devices
|
Locked | Locked | Locked |
Investor details for Intera Oncology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intera Oncology
Investment portfolio details for Intera Oncology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intera Oncology
Detailed financials for Intera Oncology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intera Oncology Comparisons
Peer comparison for Intera Oncology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intera Oncology
Intera Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TriSalus Life Sciences, Cooler Heads, Luminate Medical, Delcath and Cognos Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Developer of cold cap system to prevent chemotherapy side effects
|
|
| Locked | Locked | Locked |
Developer of a medical device to prevent hair loss during chemotherapy
|
|
| Locked | Locked | Locked |
Delcath Systems, Inc. is focused on liver cancer treatments.
|
|
| Locked | Locked | Locked |
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
|
|
| Locked | Locked | Locked |
UK-based biotherapeutics company developing products for the treatment of liver and HCC cancer.
|
Detailed competitors of Intera Oncology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intera Oncology
Complete news archive for Intera Oncology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intera Oncology
Intera Oncology was founded in 2019.
Intera Oncology is headquartered in Wellesley, United States. It is registered at Wellesley, Massachusetts, United States.
Intera Oncology was founded in 2019 in Wellesley, United States, within the oncology sector. Hepatic artery infusion therapy is developed by the company to address liver metastases from colorectal cancer and cholangiocarcinoma. The Intera 3000 pump, equipped with a beaded catheter, is used to deliver floxuridine directly to the hepatic artery. Operations focus on medical device innovation for targeted cancer therapies in the United States.
Intera Oncology's top competitors include TriSalus Life Sciences, Cooler Heads and Cognos Therapeutics.
Intera Oncology offers Intera 3000 HAI Pump.
Intera Oncology has 1 investor. Key investors include Boston Scientific.